바로가기 메뉴
본문 바로가기
주메뉴 바로가기
강명주

Myoung Joo Kang

Colorectal Cancer Center

Specialty

Solid tumor(Stomach cancer, Colon cancer, Pancreatic cancer, Hepatobiliary cance

Treatment hours

Mon, Tue, Wed, Thur, Fri, Sat
Mon Tue Wed Thu Fri Sat
Education

1998. 3 ? 2002. 2 M.D.

College of Medicine

Inje University

Busan, Korea

2007. 3 ? 2009. 2 Master of Science

Postgraduate School

Inje University

Busan, Korea

2011.3- 2015.2 Ph.D.

Internal Medicine

College of Medicine

Graduate School of Kosin University

Busan, Korea

2017.4 - Associate professor

Department of Hemato-Oncology

Haeundae Paik Hospital

University of Inje College of Medicine

Busan, Korea

Career

1998. 3 ? 2002. 2 M.D.

College of Medicine

Inje University

Busan, Korea

2007. 3 ? 2009. 2 Master of Science

Postgraduate School

Inje University

Busan, Korea

2011.3- 2015.2 Ph.D.

Internal Medicine

College of Medicine

Graduate School of Kosin University

Busan, Korea

2017.4 - Associate professor

Department of Hemato-Oncology

Haeundae Paik Hospital

University of Inje College of Medicine

Busan, Korea

Main Activities

Clinicl study for solid tumor, palliative treatment, chemotherapy

Research/Publication

2006-2017 SCI, SCIE

1. Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang HM, Lee JL, Kim TW, Kang YK. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience. Eur J Cancer. Mar;48(4):492-500, 2012.

2. Kang MJ, Hong YS, Kim KP, Kim SY, Baek JY, Ryu MH, Lee JL, Chang HM, Kim MJ, Chang HJ, Kang YK, Kim TW. Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status. Invest New Drugs. Aug;30(4):1607-13, 2012

3. Kang MJ, Lee JL, Kim TW, Lee SS, Ahn S, Park DH, Lee SS, Seo DW, Lee SK, Kim MH. Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma. Acta Oncol. Sep;51(7):860-6, 2012.